Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer

Clinical Cancer Research

Volumn 6, Issue 6, 2000, Pages 2393-2400

  Ferretti, Gianluigi ^a   Curigliano, Giuseppe ^a   Pastorino, Ugo ^a   Cittadini, Achille ^b   Flamini, Giovanna ^b   Calabrò, Maria Grazia ^b   De Pas, Tommaso ^a   Orlando, Laura ^a   Mandalà, Mario ^a   Colleoni, Marco ^a   Spaggiari, Lorenzo ^a   Granone, Pier Luigi ^b   Pagliari, Gabriella ^b   De Braud, Filippo ^a   Fazio, Nicola ^a   Goldhirsch, Aron ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GEL ELECTROPHORESIS; GENE MUTATION; HUMAN; LUNG BIOPSY; LUNG LAVAGE; LUNG NON SMALL CELL CANCER; MALE; MOLECULAR CLONING; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADENOCARCINOMA; AGED; BIOPSY; BRONCHOALVEOLAR LAVAGE FLUID; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DNA MUTATIONAL ANALYSIS; ELECTROPHORESIS; EXONS; FEMALE; GENES, P53; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS P21(RAS); SENSITIVITY AND SPECIFICITY; SMOKING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034131072     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Mao, L., Hruban, R. H., Boyle, J. O., Tockman, M. and Sidransky, D. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res., 54: 1634-1637, 1994.
2. Martini, N., Bains, M. S., Burt, M. E., Zakowski, M. F., McCormack, P., Rusch, V. W., and Ginsberg, R. J. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J. Thorac. Cardiovasc. Surg., 109: 120-129, 1995.
3. Ahrendt, S. A., Chow, J. T., Xu, L. H., Yang, S. C., Eisenberger, C. F., Esteller, M., Herman, J. G., Wu, L., Decker, P. A., Jen, J., and Sidransky, D. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J. Natl. Cancer Inst., 91: 332-339, 1999.
4. Naruke, T., Goya, T., Tsuchiya, R., and Suemasu, K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J. Thorac. Cardiovasc. Surg., 96: 440-447, 1988.
5. Strauss, G. M., Kwiatkowski, D. J., Harpole, D. H., Lynch, T. J., Skarin, A. T., and Sugarbaker, D. J. Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung. J. Clin. Oncol., 13: 1265-1279, 1995.
6. Strauss, G. M., Gleason, E., and Sugarbaker, D. Screening for lung cancer. Chest, 111: 754-768, 1997.
7. Pastorino, U., Andreola, S., Tagliabue, E., Pezzella, F., Incarbone, M., Sozzi, G., Buyse, M., Menard, S., Pierotti, M., and Rilke, F. Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J. Clin. Oncol., 15: 2858-2865, 1997.
8. Mao, L., and Sidransky, D. Cancer screening based on genetic alterations in human tumors. Cancer Res., 54: 1939s-1940s, 1994.
9. Oshita, F., Nomura, I., Yamada, K., Kato, Y., Tanaka, G., and Noda, K. Detection of K-ras mutations of bronchoalveolar lavage fluid cells aids the diagnosis of lung cancer in small pulmonary lesions. Clin. Cancer Res., 5: 617-620, 1999.
10. Cho, J. Y., Kim, J. H., Lee, Y. H., Chung, K. Y., Kim, S. J., Gong, S. J., You, N. C., Chung, H. C., Roh, J. K., and Kim, B. S. Correlation between K-ras gene mutations and prognosis of patients with non-small-cell lung carcinoma. Cancer (Phila.), 79: 462-467, 1997.
11. Graziano, S. L., Gamble, G. P., Newmann, N. B., Abbott, L. Z., Rooney, M., Mookherjee, S., Lamb, M. L., Kohman, L. J., and Poiesz, B. J. Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non small cell lung cancer. J. Clin. Oncol., 17: 668-675, 1999.
12. Fukuyama, Y., Mitsudomi, T., Sugio, K., Ishida, T., Akazawa, K., and Sugimachi, K. K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer. Br. J. Cancer, 75: 1125-1130, 1997.
13. Vega, F. J., Iniesta, P., Caldes, T., Sanchez, A., Lopez, J. A., de Juan, C., Diaz-Rubio, E., Torres, A., Balibrea, J. L., and Benito, M. p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer. Br. J. Cancer, 76: 44-51, 1997.
14. Kwiatkowski, D., Harpole, D. J., Godleski, J., Herndon, J. E., Shieh, D. B., Richards, W., Blanco, R., Xu, H., Strauss, G. M., and Sugarbaker, D. Y. Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications. J. Clin. Oncol., 16: 2468-2477, 1998.
15. Sidransky, D., von Eschenbach, A., Tsai, Y., Jones, C., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., and Vogelstein, B. Identification of p53 gene mutations in bladder cancers and urine samples. Science (Washington DC), 252: 706-709, 1991.
16. Sidransky, D., Tokino, T., Hamilton, S. R., Kinzler, K. W., Levin, B., Frost, P., and Vogelstein, B. Identification of rax oncogene mutations in the stool of patients with curable colorectal tumors. Science (Washington DC), 256: 102-105, 1992;.
17. Mills, N. E., Fishman, C. L., Scholes, J., Anderson, S. E., Rom, W. N., and Jacobson, D. R. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. J. Natl. Cancer Inst., 87: 1056-1060, 1995.
18. Yakubovskaya, M. S., Spiegelman, V., Luo, F. C., Malaev, S., Salnev, A., Zborovskaya, I., Gasparyan, A., Polotsky, B., Machaladze, Z., Trachtenberg, A. C., Belitsky, G., and Ronai, Z. High frequency of K-ras mutations in normal appearing lung tissues and sputum of patients with lung cancer. Int. J. Cancer, 63: 810-814, 1995.
19. Field, J. K., Liloglou, T., Xinarianos, G., Prime, W., Fielding, P., Walshaw, M. J., and Turnbull, L. Genetic alterations in bronchial lavage as potential marker for individuals with a high risk of developing lung cancer. Cancer Res., 59: 2690-2695, 1999.
20. Pellegata, N. S., Losekoot, M., Fodde, R., Pugliese, V., Saccomanno, S., Renault, B., Bernini, L., and Ranzani, G. N. Detection of K-ras mutations by denaturing gradient gel electrophoresis (DGGE): a study on pancreatic cancer. Anticancer Res., 12: 1731-1736, 1992.
21. Borresen, A. L., Hovig, E., Smith-Sorensen, B., Malkin, D., Lystad, S., Andersen, T. L., Nesland, J. M., Isselbacher, K. J., and Friend, S. H. Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. Proc. Natl. Acad. Sci. USA, 88: 8405-8409, 1991.
22. Poland, D. Recursion relation generation of probability profiles for specific-sequence macromolecules with long-range correlations. Biopolymers, 13: 1859-1871, 1974.
23. Gotoh, O., and Tagashira, Y. Locations of frequently opening regions on natural DNAs and their relation to functional loci. Biopolymers, 20: 1043-1058, 1981.
24. Mitsudomi, T., Oyama T, Nishida, K., Ogami, A., Osaki, T., Nakanishi, R., Sugio, K., Yasumoto, K., and Sugimachi, K. p53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survival. Ann. Oncol., 6 (Suppl. 3): S9-S13, 1995.
25. Rodenhuis, S., Slebos, R. J. C., Boot, A, J. M., Evers, S. G., Mooi, W. J., Wagenaar, S. S., van Bodegom, P. C., and Bos, J. L. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res., 48: 5738-5741, 1988.
26. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Hams, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
27. Sozzi, G., Pastorino, U., Moiraghi, L., Tagliabue, E., Pezzella, F., Ghirelli, C., Tornielli, S., Sard, L., Huebner, K., Pierotti, M. A., Croce, C. M., and Pilotti, S. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res., 58: 5032-5037, 1998.
28. Croce, C. M., Sozzi, G., and Huebner, K. Role of FHIT in human cancer. J. Clin. Oncol., 17: 1618-1624, 1999.
29. Tomizawa, Y., Kohno, T., Fujita, T., Kiyama, M., Saito, R., Noguchi, M., Matsuno, Y., Hirohashi, S., Yamaguchi, N., Nakajima, T., and Yokota, J. Correlation between the status of the p53 gene and survival in patients with stage I non-small-cell lung carcinoma. Oncogene, 18: 1007-1014, 1999.
30. Miyake, M., Adachi, M., Huang, C., Higashiyama, M., Kodama, K., and Taki, T. A novel molecular staging protocol for non-small-cell lung cancer. Oncogene, 18: 2397-2404, 1999.
31. de Juan, C., Iniesta, P., Vega, F. J., Peinado, M. A., Fernandez, C., Caldes, T., Massa, M. J., Lopez, J. A., Sanchez, A., Torres, A. J., Balibrea, J. L., and Benito, M. Prognostic value of genomic damage in non-small-cell lung cancer. Br. J. Cancer, 77: 1971-1977, 1998.
32. Kubik, A., Parkin, D. M., Khlat, M., Erban, J., Polak, J., and Adamec, M. Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high risk males in Czechoslovakia. Int. J. Cancer, 45: 26-33, 1990.
33. De Gracia, J., Bravo, C., Miravitlles, M., Tallada, N., Orriols, R., Bellmunt, J., Vendrell, M., and Morell, F. Diagnostic value of bronchoalveolar lavage in peripheral lung cancer. Am. Rev. Respir. Dis., 147: 649-652, 1993.
34. Gazdar, F., and Minna, J. D. Molecular detection of early lung cancer. J. Natl. Cancer Inst., 91: 299-301, 1999.
35. Bechtel, J., Kelley, W., Petty, T., Patz, D., and Saccomanno, G. Outcome of 51 patients with roentgenographically occult lung cancer detected by sputum cytologic testing: a community hospital program. Arch. Intern. Med., 154: 975-980, 1994.
36. Macek, M., Jr., Mercier, B., Mackova, A., Miller, P. W., Hamosh, A., Ferec, C., and Cutting, G. Sensitivity of the denaturing gradient gel electrophoresis technique in detection of known mutations and novel Asian mutations in the CFTR gene. Hum. Mutat., 9: 136-147, 1999.
37. Trulzsch, B., Krohn, K., Wonerow, P., and Paschke, R. DGGE is more sensitive for the detection of somatic point mutations than direct sequencing. Biotechniques, 27: 266-268, 1999.
38. Arnold, N., Gross, E., Schwarz-Boeger, U., Pfisterer, J., Jonat, W., and Kiechle, M. A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers. Hum. Mutat., 14: 333-339, 1999.
39. Strauss, B. S. Silent and multiple mutations in p53 and the question of the hypermutability of tumors. Carcinogenesis (Lond.), 18: 1445-1452, 1997.